Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETON | AMGN | GILD | VRTX | REGN |
| Company | Eton Pharmaceutcials Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.27 | 272.14 | 67.09 | 404.00 | 905.66 |
| High | 3.46 | 274.48 | 67.68 | 406.86 | 912.74 |
| Low | 3.25 | 271.05 | 67.00 | 403.47 | 903.83 |
| Last | 3.28 | 273.54 | 67.03 | 404.91 | 907.32 |
| Change | +0.03 | +1.63 | +0.08 | +4.99 | +7.16 |
| % Change | +0.92% | +0.60% | +0.12% | +1.25% | +0.80% |
| Volume | 23,267 | 2,493,212 | 5,233,721 | 1,069,917 | 340,995 |
| 20-Day Average Volume | 57,028 | 2,216,500 | 6,335,001 | 977,286 | 442,465 |
| Previous Close | 3.25 | 271.91 | 66.95 | 399.92 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.46 | 271.99 | 69.34 | 404.17 | 929.14 |
| 20-Day Raw Stochastic | 23.36% | 46.12% | 14.18% | 45.66% | 19.57% |
| 20-Day Relative Strength | 37.63% | 48.69% | 32.82% | 47.90% | 39.70% |
| Weighted Alpha | -28.08 | +11.45 | -20.86 | +17.74 | +14.00 |
| Today's Opinion | 88% Sell | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 24% Sell | 8% Buy | 88% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.82% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | +2.72% since 04/16/24 | +1.47% since 04/16/24 |
| Low | 3.03 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 891.46 on 04/19/24 |
| High | 3.46 on 04/23/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -17.17% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | -2.59% since 03/22/24 | -6.19% since 03/22/24 |
| Low | 3.03 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.10 on 04/02/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -26.62% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | -7.91% since 01/23/24 | -4.95% since 01/23/24 |
| Low | 3.03 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.75 on 02/06/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -15.25% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +10.13% since 10/23/23 | +14.05% since 10/23/23 |
| Low | 3.03 on 04/17/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 5.11 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 83,486 | 145,845,984 | 83,357,904 | 103,362,928 | 98,803,360 |
| Shares Outstanding, K | 25,688 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 31,640,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -940,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 7,310,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -2,260,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 1.17 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 03/14/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 29.34 | 23.86 |